We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Bill Seeks to Eliminate REMS as Anti-Generic Tool
House Bill Seeks to Eliminate REMS as Anti-Generic Tool
A new bipartisan House bill would stop brandmakers from relying on a drug-control program to deny generics firms the batch samples they need to put together an ANDA.